Evidence map›Paper›PMID 26407611›Full record

ArticleCellular and molecular life sciences : CMLS2016

Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression.

Dominik Kraus, Jan Reckenbeil, Matthias Wenghoefer, Helmut Stark, Matthias Frentzen, Jean-Pierre Allam, Natalija Novak, Stilla Frede, Werner Götz, Rainer Probstmeier and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Major roles of the circadian clock in cancer.Cancer biology & medicine · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Ghrelin-Mediated Regeneration and Plasticity After Nervous System Injury.Frontiers in cell and developmental biology · 2021
    Review
  15. The Effects of Low-Dose and High-Dose Decoctions of Fructus aurantii in a Rat Model of Functional Dyspepsia.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Dominik KrausDepartment of Prosthodontics, Preclinical Education, and Material Science, University of Bonn, Bonn, Germany.
Jan ReckenbeilDepartment of Prosthodontics, Preclinical Education, and Material Science, University of Bonn, Bonn, Germany.
Matthias WenghoeferDepartment of Oral and Maxillofacial Plastic Surgery, University of Bonn, Bonn, Germany.
Helmut StarkDepartment of Prosthodontics, Preclinical Education, and Material Science, University of Bonn, Bonn, Germany.
Matthias FrentzenDepartment of Periodontology, Operative and Preventive Dentistry, University of Bonn, Welschnonnenstr. 17, 53111, Bonn, Germany.
Jean-Pierre AllamDepartment of Dermatology and Allergy, University of Bonn, Bonn, Germany.
Natalija NovakDepartment of Dermatology and Allergy, University of Bonn, Bonn, Germany.
Stilla FredeDepartment of Anesthesiology and Intensive Care Medicine, University of Bonn, Bonn, Germany.
Werner GötzDepartment of Orthodontics, University of Bonn, Bonn, Germany.
Rainer ProbstmeierDepartment of Nuclear Medicine, University of Bonn, Bonn, Germany.
Rainer MeyerInstitute of Physiology II, University of Bonn, Bonn, Germany.
Jochen WinterDepartment of Periodontology, Operative and Preventive Dentistry, University of Bonn, Welschnonnenstr. 17, 53111, Bonn, Germany. jochen.winter@ukb.uni-bonn.de.
University of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In our study, ghrelin was investigated with respect to its capacity on proliferative effects and molecular correlations on oral tumor cells. The presence of all molecular components of the ghrelin system, i.e., ghrelin and its receptors, was analyzed and could be detected using real-time PCR and immunohistochemistry. To examine cellular effects caused by ghrelin and to clarify downstream-regulatory mechanisms, two different oral tumor cell lines (BHY and HN) were used in cell culture experiments. Stimulation of either cell line with ghrelin led to a significantly increased proliferation. Signal transduction occurred through phosphorylation of GSK-3β and nuclear translocation of β-catenin. This effect could be inhibited by blocking protein kinase A. Glucose transporter1 (GLUT1), as an important factor for delivering sufficient amounts of glucose to tumor cells having high requirements for this carbohydrate (Warburg effect) was up-regulated by exogenous and endogenous ghrelin. Silencing intracellular ghrelin concentrations using siRNA led to a significant decreased expression of GLUT1 and proliferation. In conclusion, our study describes the role for the appetite-stimulating peptide hormone ghrelin in oral cancer proliferation under the particular aspect of glucose uptake: (1) tumor cells are a source of ghrelin. (2) Ghrelin affects tumor cell proliferation through autocrine and/or paracrine activity. (3) Ghrelin modulates GLUT1 expression and thus indirectly enhances tumor cell proliferation. These findings are of major relevance, because glucose uptake is assumed to be a promising target for cancer treatment.

Indexed as

beta CateninCell LineCell Line, TumorCell ProliferationCells, CulturedGene Expression Regulation, NeoplasticGhrelinGlucoseGlucose Transporter Type 1Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansMouthMouth NeoplasmsRNA, MessengerSignal Transductionbeta CateninGhrelinGlucoseGlucose Transporter Type 1Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanRNA, MessengerSLC2A1 protein, humanGlucose uptakeOral squamous cell carcinoma cellsOrexigenic peptide

Identifiers

PMID26407611
PMCPMC11108541
OpenAlexW1764209305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.